Medicared For All Logo

Mark Jennings in Tulsa, Oklahoma

Home Oklahoma Tulsa

Mark Jennings has Hematology/oncology as his primary medical specialty. Their primary office is: 12697 E 51st St in Tulsa, Oklahoma. There is an additional office location, for a total of two, for Mark Jennings that can be viewed further down.

They're a part of the: Oklahoma Cancer Specialists And Research Institute, Llc medical group which has around 49 members. You can call their office at 918-505-3200 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Oklahoma College Of Medicine and graduated in 2009 (around 15 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Mark B Jennings Office Phone and Directions

Mark Jennings
Oklahoma Cancer Specialists And Research Institute, Llc
12697 E 51st St
Tulsa, Oklahoma 74146
918-505-3200


Patient Ratings
Please rate your experience with Mark Jennings below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 918-505-3200


Enter a starting address:


Healthcare Info for Mark Jennings

Medical School: University Of Oklahoma College Of Medicine
Graduation Year: 2009
The Primary Medical Specialty for Mark Jennings is listed as: Hematology/oncology
Approximate Years of Experience: 15
PAC (PECOS ID)#: 8426204322
NPI #: 1336379783
NPI Created On: 07/20/2009
NPI Last Updated Listed as: 09/12/2012
Primary Taxonomy Code: 390200000X
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • CommunityCare HMO Inc.
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, ENGLISH.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Collection of blood specimen from a completely implantable venous access device
  3. Collection of blood specimen from central or peripheral venous catheter
  4. Declotting infusion of implanted central venous access device or catheter
  5. Mri scan of brain before and after contrast
  6. X-ray of chest, 2 views
  7. Ct scan chest
  8. Ct scan chest with contrast
  9. Ct scan of abdomen and pelvis with contrast
  10. Ct scan guidance for insertion of radiation therapy fields
  11. Nuclear medicine study with ct imaging skull base to mid-thigh
  12. Blood test, comprehensive group of blood chemicals
  13. Urine microalbumin (protein) analysis
  14. Carcinoembryonic antigen (cea) protein level
  15. Blood creatinine level
  16. Ferritin (blood protein) level
  17. Gammaglobulin (immune system protein) measurement
  18. Iron level
  19. Iron binding capacity
  20. Lactate dehydrogenase (enzyme) level

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788129323

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802204263

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: ZEJULA

Open Associated Drug #1: 69656-103-90


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832187457

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832187461

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832187473

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783717033

Being Disputed:: No

Product Related: Yes


Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783597457

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01


Payments Total: $22

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783597529

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812733393

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: SCEMBLIX

Open Associated Drug #1: 0078-1098-20

Drug or Biological: Drug

Product Category #2: HEMATOLOGY

Name Of Drug #2:: TASIGNA

Associated Drug #2: 0078-0526-51


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2780137;EPRINTS;10575879

Record ID:: 845874571

Being Disputed:: No

Product Related: Yes


Additional Office Locations

1. Stillwater Medical Center Authority
1301 W 6th Ave
Stillwater, OK 74074
Suite 208
Group Members: 143

Phone: 918-505-3200

Enter a starting address:


Hematology/oncology Professionals in Tulsa

12697 E 51st St
Tulsa, OK
Oklahoma Cancer Specialists And Research Institute, Llc

8801 S 101st E Ave
Tulsa, OK
Genesiscare Landmark Oklahoma Cancer Care Pc

6600 S Yale Ave
Tulsa, OK
Warren Clinic Inc

6161 S Yale Ave
Tulsa, OK
Saint Francis Hospital, Inc.

12697 E 51st St
Tulsa, OK
Oklahoma Cancer Specialists And Research Institute, Llc

6161 S Yale Ave
Tulsa, OK
Saint Francis Hospital, Inc.

Providers in Oklahoma Cancer Specialists And Research Institute, Llc

1.Amisty Beck

901 N Strong Blvd
Mcalester Ok 74501-4206
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner

2.Lisa Bloxham

12697 E 51st St
Tulsa Ok 74146-6236
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner

3.Lise Brown

800 W Boise Cir
Broken Arrow Ok 74012-4974
Oklahoma Cancer Specialists And Research Institute, Llc
Dermatology

4.Steven Buck

12697 E 51st St
Tulsa Ok 74146-6236
Oklahoma Cancer Specialists And Research Institute, Llc
Medical Oncology

5.Andrea Carpenter

12697 E 51st St
Tulsa Ok 74146-6236
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner

6.Patricia Catts

3470 E Frank Phillips Blvd
Bartlesville Ok 74006-2406
Oklahoma Cancer Specialists And Research Institute, Llc
Nurse Practitioner

View all 49 members of Oklahoma Cancer Specialists And Research Institute, Llc medical group